Valuation: BELE LIFEPAR

Market Cap 46.6M 40.81M 37.59M 34.89M 66.25M 4.44B 67.15M 450M 175M 2.18B 175M 171M 7.56B P/E 2022 *
-
P/E 2023 210x
Enterprise Value 46.65M 40.86M 37.63M 34.93M 66.33M 4.45B 67.23M 450M 175M 2.18B 175M 171M 7.57B EV / Sales 2022 *
-
EV / Sales 2023 -
Free-Float
-
Yield 2022 *
-
Yield 2023 -
1 day+1.37%
Current month-89.20%
Current year-89.20%
3 years 0.32
Extreme 0.3151
13.4
5 years 0.32
Extreme 0.3151
13.4
10 years 0.32
Extreme 0.3151
13.4

Financials

2022 2023
Net sales - -
Net income -35.39K -30.99K -28.55K -26.5K -50.32K -3.38M -51K -342K -133K -1.66M -133K -130K -5.74M 404K 354K 326K 302K 574K 38.52M 582K 3.9M 1.52M 18.91M 1.52M 1.48M 65.55M
Net Debt 1.09M 957K 881K 818K 1.55M 104M 1.57M 10.55M 4.11M 51.15M 4.1M 4.01M 177M 56.58K 49.55K 45.64K 42.37K 80.45K 5.4M 81.54K 546K 213K 2.65M 212K 208K 9.19M
Logo BELE LIFEPAR
OSR Holdings, Inc. is a global healthcare company, dedicated to advancing healthcare outcomes and improving the quality of life for people and their families. The Company is focused on building and developing a portfolio of transformative therapies and healthcare solutions. The Company's operating businesses (through its three wholly owned subsidiaries) include developing oral immunotherapies for the treatment of cancer, developing design-augmented biologics for age-related and other degenerative diseases and neurovascular intervention medical device and systems distribution in Korea. The Company has business operations in the United States, Europe and South Korea.
Employees
-
Sector
-
Date Price Change Volume
26-07-06 US$0.3250 +1.37% 490,808
26-07-02 US$0.3206 +3.42% 1,323,881
26-07-01 US$0.3100 -1.99% 826,838
26-06-30 US$0.3163 -1.46% 351,432
26-06-29 US$0.3210 -3.89% 250,629
  1. Stock Market
  2. Stocks
  3. BLAC Stock